Year |
Citation |
Score |
2024 |
Gupta V, Kong GXY, Singh A, Panigrahi A, Gupta S, Prea S, Vingrys AJ. Measuring Visual Fields in Children With Glaucoma Using a Portable Tablet. Translational Vision Science & Technology. 13: 10. PMID 38743410 DOI: 10.1167/tvst.13.5.10 |
0.621 |
|
2023 |
Prea S, Guymer R, Kong G, Vingrys A. Performance of a Smart Device over 12-Months for Home Monitoring of Patients with Intermediate Age-Related Macular Degeneration. Journal of Clinical Medicine. 12. PMID 37048613 DOI: 10.3390/jcm12072530 |
0.665 |
|
2022 |
Prea SM, Vingrys AJ, Kong GYX. Test Reliability and Compliance to a Twelve-Month Visual Field Telemedicine Study in Glaucoma Patients. Journal of Clinical Medicine. 11. PMID 35893408 DOI: 10.3390/jcm11154317 |
0.645 |
|
2021 |
Bedggood P, Prea SM, Kong YXG, Vingrys AJ. Scaling the size of perimetric stimuli reduces variability and returns constant thresholds across the visual field. Journal of Vision. 21: 2. PMID 34617957 DOI: 10.1167/jov.21.11.2 |
0.606 |
|
2021 |
Prea SM, Kong GYX, Guymer RH, Sharangan P, Baglin EK, Vingrys AJ. The short-term compliance and concordance to in clinic testing for tablet-based home monitoring in age-related macular degeneration. American Journal of Ophthalmology. PMID 34509437 DOI: 10.1016/j.ajo.2021.09.003 |
0.636 |
|
2020 |
Prea SM, Kong GY, Guymer RH, Vingrys AJ. Uptake, persistence, and performance of weekly home monitoring of visual field in a large cohort of patients with glaucoma. American Journal of Ophthalmology. PMID 33221287 DOI: 10.1016/j.ajo.2020.10.023 |
0.649 |
|
2018 |
Prea SM, Kong YXG, Mehta A, He M, Crowston JG, Gupta V, Martin KR, Vingrys AJ. Six-month longitudinal comparison of a portable tablet perimeter with the Humphrey Field Analyser. American Journal of Ophthalmology. PMID 29550190 DOI: 10.1016/j.ajo.2018.03.009 |
0.608 |
|
2018 |
Tu L, Wang JH, Barathi VA, Prea SM, He Z, Lee JH, Bender J, King AE, Logan GJ, Alexander IE, Bee YS, Tai MH, Dusting GJ, Bui BV, Zhong J, et al. AAV-mediated gene delivery of the calreticulin anti-angiogenic domain inhibits ocular neovascularization. Angiogenesis. PMID 29318471 DOI: 10.1007/S10456-017-9591-4 |
0.659 |
|
2017 |
Bee YS, Tu L, Sheu SJ, Lin HC, Tang JH, Wang JH, Prea SM, Dusting GJ, Wu DC, Zhong J, Bui BV, Tai MH, Liu GS. Gene delivery of calreticulin anti-angiogenic domain attenuates the development of choroidal neovascularization in rats. Human Gene Therapy. PMID 28363247 DOI: 10.1089/hum.2016.035 |
0.634 |
|
2015 |
Prea SM, Chan EC, Dusting GJ, Vingrys AJ, Bui BV, Liu GS. Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy. Journal of Ophthalmology. 2015: 201726. PMID 25821585 DOI: 10.1155/2015/201726 |
0.653 |
|
Show low-probability matches. |